Chicken collagen hydrolysate was given to 15 mildly hypertensive subjects for 4 weeks. Blood pressure was significantly decreased by 11.8 mmHg (P < 0:01). A reduction in plasma renin activity was observed in blood test after intake. A colony assay of endothelial progenitor cells in blood samples from non-smokers revealed an approximately 30% increase in the number of colonies.
Chicken collagen hydrolysate was given to 15 mildly hypertensive subjects for 4 weeks. Blood pressure was significantly decreased by 11.8 mmHg (P < 0:01). A reduction in plasma renin activity was observed in blood test after intake. A colony assay of endothelial progenitor cells in blood samples from non-smokers revealed an approximately 30% increase in the number of colonies.
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Chicken extract is used in food cultures all over the world. Chicken soup is known to contain abundant nitrogen compounds such as free amino acids and peptides as well as inosinic acid, and taste sweeter than beef or pork soup. 1) In addition, it has been used in yaku-zen (herbal medicine-based Chinese foods) for the improvement of frail constitution and poor blood circulation from ancient times in Eastern countries. Chicken soup was found to improve health under scientific conditions by Nagai et al. and Geissler et al. 2, 3) To elucidate how chicken extract acts, we have studied its effects on cardiovascular diseases. We found that a peptide (Gly-Phe-Hyp-Gly-Thr-Hyp-Gly-LeuHyp-Gly-Phe) derived from type I collagen obtained from a hydrolyzed chicken breast muscle extract inhibited angiotensin-I converting enzyme (ACE) and lowered blood pressure in spontaneously hypertensive rats (SHRs). 4, 5) We have also reported that chicken collagen hydrolysate obtained from type I collagen in chicken legs had the same effects, due to an ACEinhibitory peptide (Gly-Ala-Hyp-Gly-Leu-Hyp-GlyPro). 6) There is no evidence of these effects of chicken collagen hydrolysate in humans. In this study, we examined to determine whether chicken collagen hydrolysate, which includes chicken collagen octa-peptide (C-COP), would have a hypotensive action on people with prehypertension (SBP, 120-139 mmHg or DBP, 80-89 mmHg) and mild hypertension (SBP, 140-159 mmHg or DBP, 90-99 mmHg). We also investigated to determine whether it can repair endothelial progenitor cells (EPCs) in impaired blood vessels by examining its activity by its effect on EPCs in a colony assay.
Collagen extracted from solubilizing yellow portions of chicken legs with claws by acid treatment was digested with an enzyme from Aspergillus oryzae (Mitsubishi Foods Chemical, Tokyo) to produce collagen peptides with lower molecular weights. Fractions of less than 3,000 Da recovered on an ultrafilter membrane were used as C-COP.
The 15 subjects (5 men, 58:2 AE 15:4 year old, BMI ¼ 28:1 AE 5:0, and 10 women, 53:3 AE 11:2 year old, BMI ¼ 23:6 AE 1:7) were selected as eligible for the study by the principal investigator, who had examined the subjects within 1 month before the study. They had high systolic blood pressure (SBP) (135:8 AE 13:9 mmHg), and were not being treated for hypertension. The subjects were fully informed of the purpose, methods, expected drawbacks and other requirements of the study, and each gave written informed consent.
The 15 subjects received the test food (5.2 g of C-COP) at breakfast every day for 4 weeks. They visited the doctor and were measured for blood pressure 3 times on each arm on the first day of the study, and at 2 and 4 weeks after the start. They were instructed to live as usual during the study period and not to change their diet or exercise intensity. Blood samples were collected on the first day of the study and at 4 weeks for biochemical examination (SRL, Tokyo).
The study complied with ''Good Clinical Practice'' (GCP), and was performed in accordance with clinical trial protocols approved by the ethics committee of Nippon Meat Packers, Inc., and the institutional review board of Ogikubo Clinical Pharmacology Clinic.
Blood samples (10 ml) from five non-smokers were collected at the start and the end of the study for EPC colony assay following to Ikeda et al. at Gentier Biosystems (Tokyo). 7) In the long-term intake study, SBP was significantly less (by 7.4 mmHg) at 2 weeks than the baseline, and was further reduced (by a total 11.8 mmHg) at 4 weeks (Fig. 1) . DBP also declined by 4.0 mmHg and 4.1 mmHg at 2 weeks and 4 weeks respectively. Heart rate counts did not change during the study (from 73:7 AE 10:5 to y To whom correspondence should be addressed. Tel: +81-29-847-7815; Fax: +81-29-847-7824; E-mail: a.egusa@nipponham.co.jp Abbreviations: ACE, angiotensin-I converting enzymes; SHR, spontaneously hypertensive rat; EPC, endothelial progenitor cell; C-COP, chicken collagen octa-peptide; SBP, systolic blood pressure; PRA, plasma renin activity; RAS, renin-angiotensin system; WBC, white blood cell counts; RBC, red blood cell counts; HGB, hemoglobin; HCT, hematocrit; PLT, platelet; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; GLU, glucose; TG, triglyceride; TCH, total cholesterol; TP, total protein; ALB, albumin; AST, asparate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; Tbil, total bilirubin; ALP, alkaline phosphatase; GTP, -glutamyltranspeptidase; UN, urine nitrogen; CREA, creatinine; UA, uric acid; PRC, renin concentration 72:8 AE 9:8). Plasma renin activity (PRA, measured by radio immunoassay) at the completion of the study was 30% less than baseline (Table 1) . Renin catalyzes the production of angiotensin-I and is a rate-limiting enzyme in the renin-angiotensin system (RAS), which is involved in sodium retention and the contraction of peripheral nerves. Accordingly, renin inhibitors are used to treat RAS inhibition. However, only the drug aliskiren has been reported to date, to being orally administrable. 8) We have reported that C-COP inhibition of ACE (IC 50 ¼ 0:13 mg/ml) is due to an inhibitory peptide, Gly-Ala-Hyp-Gly-Leu-Hyp-Gly-Pro (IC 50 ¼ 29:4 mM) and so we expect that C-COP inhibition of renin, at the head of the RAS cascade, as well as ACE inhibition would reduce the production of angiotensin II, a factor involved in vasoconstriction by chymase, and reduce the side effects specific to ACE inhibitors, such as dry cough. In fact, no cases of cough or head pain attributable to C-COP intake were reported in this study. Because there are no reports of peptidic kinin inhibitors that can be administered orally, we intend to identify the substance in C-COP.
We performed a colony assay of EPCs to estimate the effects of C-COP intake on blood vessels. EPCs are recruited from bone marrow, circulate in the blood, and play an important role in repairing endothelial cells at damaged sites in tissues.
9) The number of EPCs falls and their functions become more impaired as the risk for cardiovascular disease becomes higher.
10) EPC senescence and decreases in telomerase activity might be involved in these impairments, according to a study using SHR/Ism and DOCA-salt hypertensive rats.
11) Among the subjects in this study, the numbers and sizes of the colonies before and after intake were examined using peripheral blood of five subjects without the smoking habit because EPC have been reported to show a negative correlation with smoking.
12) The 4-week C-COP intake significantly increased the numbers of colonies (Fig. 2) . EPC differentiation and senescence is associated with angiotensin II, 13) and 4-week administration of ramipril, an ACE inhibitor, produced a 1.5-fold increase in circulating EPC in patients with coronary artery disease. 14) On the other hand, there have been no reports that food components can increase EPC in peripheral blood. We plan to determine whether C-COP can reduce the risk for cardiovascular disease by repairing blood vessels in addition to reducing hypertension.
In conclusion, intake of C-COP for 4 weeks reduced blood pressure in mildly hypertensive subjects by inhibiting both ACE and PRA, and increased EPC activity in the peripheral blood. This study indicates that food components can inhibit PRA and increase EPC activity. C-COP might help protect blood vessels through activation of EPCs as well as by reducing blood pressure. 
